The Role of Radiofrequency Ablation in the Management of Barrett's Esophagus

Gastrointestinal Endoscopy Clinics of North America

Volumn 21, Issue 1, 2011, Pages 95-109

  Bulsiewicz, William J ^a   Shaheen, Nicholas J ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Barrett's esophagus; Dysplasia; Intestinal metaplasia; Radiofrequency ablation

Indexed keywords

ARGON PLASMA COAGULATION; BARRETT ESOPHAGUS; COST EFFECTIVENESS ANALYSIS; DISEASE COURSE; DYSPLASIA; ENDOSCOPIC MUCOSAL RESECTION; ESOPHAGUS CARCINOMA; ESOPHAGUS RESECTION; HEALTH CARE COST; HUMAN; METAPLASIA; PATIENT SAFETY; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; RADIOFREQUENCY ABLATION; REVIEW; SURGICAL EQUIPMENT; TREATMENT OUTCOME; TUMOR ABLATION;

BARRETT ESOPHAGUS; CATHETER ABLATION; ESOPHAGECTOMY; ESOPHAGUS; HUMANS; PRECANCEROUS CONDITIONS;

EID: 78649599781     PISSN: 10525157     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.giec.2010.09.009     Document Type: Review

References (45)

1. Ronkainen J., Aro P., Storskrubb T., et al. Prevalence of Barrett's esophagus in the general population: an endoscopic study. Gastroenterology 2005, 129(6):1825-1831.
2. Pohl H., Welch H.G. The role of overdiagnosis and reclassification in the marked increase of esophageal adenocarcinoma incidence. J Natl Cancer Inst 2005, 97(2):142-146.
3. Eloubeidi M.A., Mason A.C., Desmond R.A., et al. Temporal trends (1973-1997) in survival of patients with esophageal adenocarcinoma in the United States: a glimmer of hope?. Am J Gastroenterol 2003, 98(7):1627-1633.
4. Williams V.A., Watson T.J., Herbella F.A., et al. Esophagectomy for high grade dysplasia is safe, curative, and results in good alimentary outcome. J Gastrointest Surg 2007, 11(12):1589-1597.
5. Schnell T.G., Sontag S.J., Chejfec G., et al. Long-term nonsurgical management of Barrett's esophagus with high-grade dysplasia. Gastroenterology 2001, 120(7):1607-1619.
6. Brandt L.J., Kauvar D.R. Laser-induced transient regression of Barrett's epithelium. Gastrointest Endosc 1992, 38(5):619-622.
7. Berenson M.M., Johnson T.D., Markowitz N.R., et al. Restoration of squamous mucosa after ablation of Barrett's esophageal epithelium. Gastroenterology 1993, 104(6):1686-1691.
8. Rice T.W., Falk G.W., Achkar E., et al. Surgical management of high-grade dysplasia in Barrett's esophagus. Am J Gastroenterol 1993, 88(11):1832-1836.
9. Shaheen N.J., Sharma P., Overholt B.F., et al. Radiofrequency ablation in Barrett's esophagus with dysplasia. N Engl J Med 2009, 360(22):2277-2288.
10. Overholt B.F., Lightdale C.J., Wang K.K., et al. Photodynamic therapy with porfimer sodium for ablation of high-grade dysplasia in Barrett's esophagus: international, partially blinded, randomized phase III trial. Gastrointest Endosc 2005, 62(4):488-498.
11. Fleischer D.E., Overholt B.F., Sharma V.K., et al. Endoscopic ablation of Barrett's esophagus: a multicenter study with 2.5-year follow-up. Gastrointest Endosc 2008, 68(5):867-876.
12. Goldberg S.N. Radiofrequency tumor ablation: principles and techniques. Eur J Ultrasound 2001, 13(2):129-147.
13. Nath S., Haines D.E. Biophysics and pathology of catheter energy delivery systems. Prog Cardiovasc Dis 1995, 37(4):185-204.
14. Dunkin B.J., Martinez J., Bejarano P.A., et al. Thin-layer ablation of human esophageal epithelium using a bipolar radiofrequency balloon device. Surg Endosc 2006, 20(1):125-130.
15. Lyday W.D., Corbett F.S., Kuperman D.A., et al. Radiofrequency ablation of Barrett's esophagus: outcomes of 429 patients from a multicenter community practice registry. Endoscopy 2010, 42(4):272-278.
16. Vassiliou M.C., von Renteln D., Wiener D.C., et al. Treatment of ultralong-segment Barrett's using focal and balloon-based radiofrequency ablation. Surg Endosc 2010, 24(4):786-791.
17. Pouw R.E., Wirths K., Eisendrath P., et al. Efficacy of radiofrequency ablation combined with endoscopic resection for Barrett's esophagus with early neoplasia. Clin Gastroenterol Hepatol 2010, 8(1):23-29.
18. Velanovich V. Endoscopic endoluminal radiofrequency ablation of Barrett's esophagus: initial results and lessons learned. Surg Endosc 2009, 23(10):2175-2180.
19. Ganz R.A., Overholt B.F., Sharma V.K., et al. Circumferential ablation of Barrett's esophagus that contains high-grade dysplasia: a U.S. multicenter registry. Gastrointest Endosc 2008, 68(1):35-40.
20. Gondrie J.J., Pouw R.E., Sondermeijer C.M., et al. Stepwise circumferential and focal ablation of Barrett's esophagus with high-grade dysplasia: results of the first prospective series of 11 patients. Endoscopy 2008, 40(5):359-369.
21. Gondrie J.J., Pouw R.E., Sondermeijer C.M., et al. Effective treatment of early Barrett's neoplasia with stepwise circumferential and focal ablation using the HALO system. Endoscopy 2008, 40(5):370-379.
22. Hernandez J.C., Reicher S., Chung D., et al. Pilot series of radiofrequency ablation of Barrett's esophagus with or without neoplasia. Endoscopy 2008, 40(5):388-392.
23. Roorda A.K., Marcus S.N., Triadafilopoulos G. Early experience with radiofrequency energy ablation therapy for Barrett's esophagus with and without dysplasia. Dis Esophagus 2007, 20(6):516-522.
24. Sharma V.K., Jae Kim H., Das A., et al. Circumferential and focal ablation of Barrett's esophagus containing dysplasia. Am J Gastroenterol 2009, 104(2):310-317.
25. Shaheen N.J., Fleischer D.E., Eisen G.M., et al. Durability of epithelial reversion after radiofrequency ablation: follow-up of the AIM dysplasia trial. Gastroenterology 2010, 138(5 Suppl 1):S16-S17.
26. Shaheen N.J., Greenwald B.D., Peery A.F., et al. Safety and efficacy of endoscopic spray cryotherapy for Barrett's esophagus with high-grade dysplasia. Gastrointest Endosc 2010, 71(4):680-685.
27. Inadomi J.M., Somsouk M., Madanick R.D., et al. A cost-utility analysis of ablative therapy for Barrett's esophagus. Gastroenterology 2009, 136(7):2101-2114. e2101-6.
28. Eldaif S.M., Lin E., Singh K.A., et al. Radiofrequency ablation of Barrett's esophagus: short-term results. Ann Thorac Surg 2009, 87(2):405-410. [discussion: 410-1].
29. Sharma V.K., Kim H.J., Das A., et al. A prospective pilot trial of ablation of Barrett's esophagus with low-grade dysplasia using stepwise circumferential and focal ablation (HALO system). Endoscopy 2008, 40(5):380-387.
30. Sharma V.K., Wang K.K., Overholt B.F., et al. Balloon-based, circumferential, endoscopic radiofrequency ablation of Barrett's esophagus: 1-year follow-up of 100 patients. Gastrointest Endosc 2007, 65(2):185-195.
31. Sharma P., Falk G.W., Weston A.P., et al. Dysplasia and cancer in a large multicenter cohort of patients with Barrett's esophagus. Clin Gastroenterol Hepatol 2006, 4(5):566-572.
32. Prasad G.A., Wang K.K., Buttar N.S., et al. Predictors of stricture formation after photodynamic therapy for high-grade dysplasia in Barrett's esophagus. Gastrointest Endosc 2007, 65(1):60-66.
33. Dumot J.A., Vargo J.J., Falk G.W., et al. An open-label, prospective trial of cryospray ablation for Barrett's esophagus high-grade dysplasia and early esophageal cancer in high-risk patients. Gastrointest Endosc 2009, 70(4):635-644.
34. Mino-Kenudson M., Ban S., Ohana M., et al. Buried dysplasia and early adenocarcinoma arising in Barrett esophagus after porfimer-photodynamic therapy. Am J Surg Pathol 2007, 31(3):403-409.
35. Van Laethem J.L., Peny M.O., Salmon I., et al. Intramucosal adenocarcinoma arising under squamous re-epithelialisation of Barrett's oesophagus. Gut 2000, 46(4):574-577.
36. Hornick J.L., Mino-Kenudson M., Lauwers G.Y., et al. Buried Barrett's epithelium following photodynamic therapy shows reduced crypt proliferation and absence of DNA content abnormalities. Am J Gastroenterol 2008, 103(1):38-47.
37. Bronner M.P., Overholt B.F., Taylor S.L., et al. Squamous overgrowth is not a safety concern for photodynamic therapy for Barrett's esophagus with high-grade dysplasia. Gastroenterology 2009, 136(1):56-64. [quiz: 351-2].
38. Pouw R.E., Gondrie J.J., Rygiel A.M., et al. Properties of the neosquamous epithelium after radiofrequency ablation of Barrett's esophagus containing neoplasia. Am J Gastroenterol 2009, 104(6):1366-1373.
39. Peters F., Kara M., Rosmolen W., et al. Poor results of 5-aminolevulinic acid-photodynamic therapy for residual high-grade dysplasia and early cancer in Barrett esophagus after endoscopic resection. Endoscopy 2005, 37(5):418-424.
40. Sampliner R.E., Camargo E., Prasad A.R. Association of ablation of Barrett's esophagus with high grade dysplasia and adenocarcinoma of the gastric cardia. Dis Esophagus 2006, 19(4):277-279.
41. Weston A.P., Sharma P., Banerjee S., et al. Visible endoscopic and histologic changes in the cardia, before and after complete Barrett's esophagus ablation. Gastrointest Endosc 2005, 61(4):515-521.
42. May A., Gossner L., Pech O., et al. Local endoscopic therapy for intraepithelial high-grade neoplasia and early adenocarcinoma in Barrett's oesophagus: acute-phase and intermediate results of a new treatment approach. Eur J Gastroenterol Hepatol 2002, 14(10):1085-1091.
43. Pech O., Behrens A., May A., et al. Long-term results and risk factor analysis for recurrence after curative endoscopic therapy in 349 patients with high-grade intraepithelial neoplasia and mucosal adenocarcinoma in Barrett's oesophagus. Gut 2008, 57(9):1200-1206.
44. Pouw R.E., Seewald S., Gondrie J.J., et al. Stepwise radical endoscopic resection for eradication of Barrett's oesophagus with early neoplasia in a cohort of 169 patients. Gut 2010, 59(9):1169-1177.
45. Van Vilsteren F.G., Pouw R.E., Seewald S., et al. A multi-center randomized trial comparing stepwise radical endoscopic resection versus radiofrequency ablation for Barrett esophagus containing high-grade dysplasia and/or early cancer. Gastrointest Endosc 2009, 69(5):AB133-AB134.